CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 432 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03568110
NCT03568110N/ACompleted

The Impact of Frailty on the Postoperative Outcomes of Gastric Cancer Surgery

Parc de Salut Mar·observational·Posted Jun 26, 2018·Updated Nov 28, 2023

In Brief

An observational study for Gastric Cancer and 3 related conditions. Completed, enrolled 432 participants across 1 site.

Detailed Summary

Background. Gastric cancer is an important health care problem even though treatment advances, and it is diagnosed mainly in elderly. Surgery is the main treatment for gastric cancer and is associated with a high rate of postoperative complications and mortality, even higher in older patients. Chronological age seems not to be the main factor influencing the worse outcome of older patients, comorbidities and frailty have also been taken into account recently. Methods. Participation in the study will be offered to all centers that are currently part of the Spanish EURECCA (EUropean REgistry of Cancer CAre) Esophagogastric Cancer Registry. The impact of the frailty on different outcome variables will be evaluated. The main outcome variable will be 90-day mortality after the intervention. Health-Related Quality of Life (HRQoL) will also be evaluated. Objective. The objective of the study is to value the impact of frailty on gastric cancer surgery outcomes therein the Spanish EURECCA Esophagogastric Cancer Registry.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 26, 2018
Enrollment StartMar 5, 2019
Primary CompletionApr 30, 2023
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 8.0 years ago